ANTITUSSIVE PHARMACOTHERAPY IN ACUTE COUGH: EFFICACY, SAFETY, AND CURRENT CLINICAL EVIDENCE

Keywords: Acute Cough, Antitussive, Dextromethorphan, Codeine, Levodropropizine, Butamirate

Abstract

Background: Acute viral cough is one of the most frequent reasons for primary-care consultation, yet evidence for commonly used antitussive agents varies widely. This review synthesizes current data on the pathophysiology, efficacy, safety, and clinical recommendations guiding antitussive pharmacotherapy.

Methods: This review synthesizes current evidence on antitussive pharmacotherapy in acute cough in adults and children. A narrative review of eligible publications indexed in PubMed, Scopus, and Google Scholar from 2013–2025 was conducted, prioritizing systematic reviews, randomized controlled trials, pharmacovigilance studies, and clinical guidelines. Search terms included “acute cough”, “antitussive”, “dextromethorphan”, “codeine”, “hydrocodone”, “levodropropizine”, “butamirate”, “benzonatate”, “ivy leaf”, “Pelargonium sidoides”, and “honey”. Relevant studies were screened and qualitatively analyzed.

Results: Acute viral cough arises from inflammatory sensitization of airway sensory pathways and heightened brainstem cough-reflex responsiveness. Opioid antitussives demonstrate limited symptomatic benefit and present substantial safety concerns, particularly in pediatric populations. Centrally acting non-opioid agents, such as dextromethorphan, show modest and inconsistent efficacy with dose-dependent toxicity. Peripherally acting antitussives—notably levodropropizine—exhibit more consistent reductions in cough severity with favorable tolerability. Complementary agents, including ivy leaf extract, Pelargonium sidoides, and honey in children over one year, offer modest symptomatic benefit with strong safety profiles. Contemporary guidelines consistently discourage routine antitussive use and emphasize the self-limiting nature of acute viral cough.

Conclusion: Evidence supports a cautious, symptom-targeted approach to pharmacologic therapy in acute viral cough, prioritizing safety and reserving antitussives for selected clinical scenarios.

References

Birring, S., de Blasio, F., Dicpinigaitis, P. v., Fontana, G., Lanata, L., Page, C., Saibene, F., & Zanasi, A. (2019). Antitussive therapy: A role for levodropropizine. In Pulmonary Pharmacology and Therapeutics (Vol. 56, pp. 79–85). Academic Press. https://doi.org/10.1016/j.pupt.2019.03.003

Murgia, V., Manti, S., Licari, A., de Filippo, M., Ciprandi, G., & Marseglia, G. L. (2020). Upper Respiratory Tract Infection-Associated Acute Cough and the Urge to Cough: New Insights for Clinical Practice. In Pediatric, Allergy, Immunology, and Pulmonology (Vol. 33, Issue 1, pp. 3–11). Mary Ann Liebert Inc. https://doi.org/10.1089/ped.2019.1135

Vittorakis, S., Anagnostakos, T., Apollonatos, G., Gaki, E., Latsios, D., Melachroinidou, M., Chorianopoulos, D., Tzortzaki, E., Katsoulis, K., Bakakos, P., Loukides, S., & Katsimpoula, S. (2024). The continuous challenge of cough in adults: A narrative review based on Hellenic Thoracic Society guidelines. In Pneumon (Vol. 37, Issue 3). European Publishing. https://doi.org/10.18332/pne/191735

Petat, H., Schuers, M., le Bas, F., Humbert, X., Rabiaza, A., Corbet, S., Vabret, A., Gouilh, M. A. R., & Marguet, C. (2025). Characterizing acute respiratory infections in primary care for better management of viral infections. Npj Primary Care Respiratory Medicine, 35(1). https://doi.org/10.1038/s41533-025-00434-w

Kandiwa, K., Thom, L., & N Schellack. (2022). A modern approach to cough management. Journals.Co.Za. https://doi.org/10.10520/EJC-MP_SAPJ_V89_N4_A7

Amos, L. B. (2022). Cough. Nelson Pediatric Symptom-Based Diagnosis: Common Diseases and Their Mimics, 27-53.e2. https://doi.org/10.1016/B978-0-323-76174-1.00003-1

Andrani, F., Aiello, M., Bertorelli, G., Crisafulli, E., & Chetta, A. (2018). Cough, a vital reflex. Mechanisms, determinants and measurements. Acta Biomedica, 89(4), 477–480. https://doi.org/10.23750/abm.v89i4.6182

Lee, K. K., Davenport, P. W., Smith, J. A., Irwin, R. S., McGarvey, L., Mazzone, S. B., Birring, S. S., Abu Dabrh, A. M., Altman, K. W., Barker, A. F., Blackhall, F., Bolser, D. C., Brightling, C., Chang, A. B., Davenport, P., el Solh, A. A., Escalante, P., Field, S. K., Fisher, D., … Vertigan, A. E. (2021). Global Physiology and Pathophysiology of Cough: Part 1: Cough Phenomenology – CHEST Guideline and Expert Panel Report. In Chest (Vol. 159, Issue 1, pp. 282–293). Elsevier Inc. https://doi.org/10.1016/j.chest.2020.08.2086

Sykes, D. L., & Morice, A. H. (2021). The Cough Reflex: The Janus of Respiratory Medicine. In Frontiers in Physiology (Vol. 12). Frontiers Media S.A. https://doi.org/10.3389/fphys.2021.684080

Naqvi, K. F., Mazzone, S. B., & Shiloh, M. U. (2025). Infectious and Inflammatory Pathways to Cough. 19, 37. https://doi.org/10.1146/annurev-physiol-031422

Singu, B., & Verbeeck, R. K. (2021). Should Codeine Still be Considered a WHO Essential Medicine?. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 24, 329–335. https://doi.org/10.18433/jpps31639

Lam, S. H. F., Homme, J., Avarello, J., Heins, A., Pauze, D., Mace, S., Dietrich, A., Stoner, M., Chumpitazi, C. E., & Saidinejad, M. (2021). Use of antitussive medications in acute cough in young children. JACEP Open, 2(3). https://doi.org/10.1002/emp2.12467

Sloan, V. S., Jones, A., Maduka, C., & Bentz, J. W. G. (2019). A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough. In Drugs - Real World Outcomes (Vol. 6, Issue 2, pp. 47–57). Springer International Publishing. https://doi.org/10.1007/s40801-019-0152-6

Oh, S., Agrawal, S., Sabir, S., & Taylor, A. (2023). Dextromethorphan. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538216/ (ncbi.nlm.nih.gov)

McCarthy, B., Bunn, H., Santalucia, M., Wilmouth, C., Muzyk, A., & Smith, C. M. (2023). Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder. Clinical Psychopharmacology and Neuroscience, 21(4), 609–616. https://doi.org/10.9758/cpn.23.1081

Ghosh, A. (2019). Comparison of safety and efficacy of dextromethorphan and levocloperastine in treatment of dry cough: a randomized open label phase IV clinical trial. International Journal of Basic & Clinical Pharmacology, 8(10), 2284. https://doi.org/10.18203/2319-2003.ijbcp20194272

Nayar, S., Vora, A., Tiwaskar, M., Jose, A., Prajapati, C., Qamra, A., & Muralidharan, P. (2025). Levodropropizine: Comprehensive Review of the Peripheral Antitussive. In Journal of Association of Physicians of India (Vol. 73, Issue 7, pp. e35–e44). Journal of Association of Physicians of India. https://doi.org/10.59556/japi.73.1056

Prasanna K, T., Pramod, J., Nitin R, V., Krishna C, V., & Anup, P. U. (2023). A Newer Approach in the Management of Cough: A Review on Levodropropizine. Journal of Respiratory Diseases, 1(3), 1–14. https://doi.org/10.14302/issn.2642-9241.jrd-23-4566

Rahurkar, S., Ouyang, J., Jonnalagadda, P., Liu, X., Zhang, S., Chiang, C., Wang, L., Shendre, A., & Li, L. (2025). Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.70061

Ebell, M. H., Merenstein, D. J., & Barrett, B. (2025). Corticosteroids, Antitussives, and Inhalers for Lower Respiratory Tract Infections in US Primary Care: A Prospective Cohort Study. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-025-09733-x

Yang, S., Hincapie-Castillo, J. M., Ke, X., Schelfhout, J., Ding, H., Sher, M. R., Zhou, L., Chang, C. Y., Wilson, D. L., & Lo-Ciganic, W. H. (2022). Evaluation of Cough Medication Use Patterns in Ambulatory Care Settings in the United States: 2003–2018. Journal of Clinical Medicine, 11(13). https://doi.org/10.3390/jcm11133671

Völp, A., Schmitz, J., Bulitta, M., Raskopf, E., Acikel, C., & Mösges, R. (2022). Ivy leaves extract EA 575 in the treatment of cough during acute respiratory tract infections: meta-analysis of double-blind, randomized, placebo-controlled trials. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-24393-1

NICE. (2019). Cough (acute): antimicrobial prescribing. NICE Guideline NG120 – Summary of the evidence. https://www.nice.org.uk/guidance/ng120/chapter/summary-of-the-evidence

Abuelgasim, H., Albury, C., & Lee, J. (2021). Effectiveness of honey for symptomatic relief in upper respiratory tract infections: a systematic review and meta-analysis. BMJ evidence-based medicine, 26(2), 57–64. https://doi.org/10.1136/bmjebm-2020-111336

Murgia, V., Ciprandi, G., Votto, M., de Filippo, M., Tosca, M. A., & Marseglia, G. L. (2021). Natural remedies for acute post-viral cough in children. Allergologia et Immunopathologia, 49(3), 173–184. https://doi.org/10.15586/AEI.V49I3.71

Thirion, D. J. G. (2019). Acute cough (Chapter 1). Canadian Pharmacists Association. https://www.pharmacists.ca/cpha-ca/assets/File/Acute_Cough.pdf

Diantini, A., Alfaqeeh, M., Permatasari, L., Nurfitriani, M., Durotulailah, L., Wulandari, W., Sitorus, T., Wilar, G., & Levita, J. (2024). Clinical Toxicology of OTC Cough and Cold Pediatric Medications: A Narrative Review. Pediatric Health, Medicine and Therapeutics, Volume 15, 243–255. https://doi.org/10.2147/phmt.s468314

Llor, C., Moragas, A., Ouchi, D., Monfà, R., Garcia-Sangenís, A., Gómez-Lumbreras, A., Pera, H., Pujol, J., & Morros, R. (2022). Effectiveness of antitussives, anticholinergics, and honey versus usual care in adults with uncomplicated acute bronchitis: a multiarm randomized clinical trial. Family Practice, 40(2), 407–413. https://doi.org/10.1093/fampra/cmac112

Meeves, S. G., Cruz-Rivera, M., Leyva, R. A., Wilson, B. L., Moreira, S. A., Gelotte, C. K., & Jayawardena, S. (2023). Objective and self-reported evidence of dextromethorphan antitussive efficacy in children, aged 6–11 years, with acute cough due to the common cold. Pediatric Pulmonology, 58(8), 2229–2239. https://doi.org/10.1002/PPUL.26416

Zanasi, A., Lanata, L., Fontana, G., Saibene, F., Dicpinigaitis, P., & de Blasio, F. (2015). Levodropropizine for treating cough in adult and children: A meta-analysis of published studies. Multidisciplinary Respiratory Medicine, 10(1). https://doi.org/10.1186/s40248-015-0014-3

Renny, M. H., Jent, V., Townsend, T., & Cerdá, M. (2022). Impact of the 2017 FDA Drug Safety Communication on Codeine and Tramadol Dispensing to Children. Pediatrics, 150(5). https://doi.org/10.1542/peds.2021-055887

Medsafe Pharmacovigilance Team. (2018, March 8). Codeine – safety concerns when used in children (Agenda item 3.2.2). Medicines Adverse Reactions Committee. https://assets.publishing.service.gov.uk/media/65d33fc20f4eb1ec90a98147/PAR_-_codeine_linctus.pdf

Sobczak, Ł., & Gorynski, K. (2020). Pharmacological aspects of over-the-counter opioid drugs misuse. In Molecules (Vol. 25, Issue 17). MDPI AG. https://doi.org/10.3390/molecules25173905

Chua, K. P., & Conti, R. M. (2021). Prescriptions for Codeine or Hydrocodone Cough and Cold Medications to US Children and Adolescents following US Food and Drug Administration Safety Communications. In JAMA Network Open (Vol. 4, Issue 11). American Medical Association. https://doi.org/10.1001/jamanetworkopen.2021.34142

Colom Gordillo, A., Martínez Sánchez, L., Pretel Echaburu, C., Trenchs Sainz de la Maza, V., Gotzens Bersch, J., & Luaces Cubells, C. (2022). Unintentional poisoning by cough and cold medications: Drugs with little usefulness and potential toxicity. Anales de pediatria, 97(5), 326–332. https://doi.org/10.1016/j.anpede.2022.09.005

Summerlin, J., & Eiland, L. S. (2025). The Use and Safety of Cough and Cold Medications in tPediatric Population. In Journal of Pediatric Pharmacology and Therapeutics (Vol. 30, Issue 1, pp. 17–26). Pediatric Pharmacy Advocacy Group, Inc. https://doi.org/10.5863/1551-6776-30.1.17

Zaremba, M., Serafin, P., & Kleczkowska, P. (2023). Antipsychotic Drugs Efficacy in Dextromethorphan-Induced Psychosis. https://doi.org/10.3390/biomedicines11010123

Mallefet, P., Armogida, M., Doll, W. J., Page, R. C., & Sandefer, E. P. (2022). A single-dose, open-label, randomized, scintigraphic study to investigate the gastrointestinal behavior of 2 triple-combination cold products (acetaminophen, phenylephrine, and dextromethorphan) in healthy male volunteers. https://doi.org/10.1186/s13063-022-06037-x

Faruqi, S., Wright, C., Thompson, R., & Morice, A. H. (2014). A randomized placebo controlled trial to evaluate the effects of butamirate and dextromethorphan on capsaicin induced cough in healthy volunteers Correspondence. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.12458

Rashitova, E. L., Zakirova, A. M., Moroz, T. B., Shayapova, D. T., Kadriev, A. G., & Kadriev, A. A. (2020). The potential of the use of antitude therapy in pediatric practice. Meditsinskiy Sovet = Medical Council, 2020(18), 58–64. https://doi.org/10.21518/2079-701X-2020-18-58-64

Shirsat, A., Trailokya, A., & Wankhede, S. (2023). Levodropropizine: A promising peripherally acting antitussive agent. In IP Indian Journal of Immunology and Respiratory Medicine (Vol. 8, Issue 2, pp. 53–61). IP Innovative Publication Pvt. Ltd. https://doi.org/10.18231/j.ijirm.2023.013

Lee, S. P., Lee, S. M., Lee, B. J., & Kang, S. Y. (2022). Effectiveness and Safety of Codeine and Levodropropizine in Patients With Chronic Cough. Journal of Korean Medical Science, 37(36). https://doi.org/10.3346/jkms.2022.37.e275

Jang, J. H., Cho, Y. J., & Jeong, S. H. (2024). Pharmacokinetic Analysis of Levodropropizine and Its Potential Therapeutic Advantages Considering Eosinophil Levels and Clinical Indications. Pharmaceuticals, 17(2). https://doi.org/10.3390/ph17020234

Kim, I., Goulding, M., Tian, F., Karami, S., Pham, T., Cheng, C., Biehl, A., & Muñoz, M. (2022). Benzonatate Exposure Trends and Adverse Events. Pediatrics, 150(6). https://doi.org/10.1542/peds.2022-057779

Era, N., Singh, R., Mukherjee, S., & Bordoloi, S. K. (2022). Benzonatate Induced Neck Stiffness: A Case Series. Journal of Medical Sciences and Health, 8(3), 280–282. https://doi.org/10.46347/jmsh.v8i3.22.210

Jin, C., Zahid, E., Sherazi, A., Majumder, M. R., & Bedi, P. (2019). Cardiac arrest due to benzonatate overdose. American Journal of Case Reports, 20, 640–642. https://doi.org/10.12659/AJCR.915151

European Medicines Agency (2017) Assessment report on Hedera helix L., folium (Revision 2). https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-hedera-helix-l-folium-revision-2_en.pdf

Kardos, P., de Zeeuw, J., Trompetter, I., Braun, S., & Ilieva, Y. (2025). Efficacy and Safety of a Single Ivy Extract Versus Two Herbal Extract Combinations in Patients with Acute Bronchitis: A Multi-Center, Randomized, Open-Label Clinical Trial. Pharmaceuticals, 18(5), 754. https://doi.org/10.3390/PH18050754/S1

Olszanecka-Glinianowicz, M., Doniec, Z., Schönknecht, K., & Almgren-Rachtan, A. (2020). The herbal medicine containing of ivy leaf dry extract in the treatment of productive cough in children. Wiadomosci Lekarskie (Warsaw, Poland : 1960), 73(4), 668–673. https://doi.org/10.36740/wlek202004108

Sierocinski, E., Holzinger, F., & Chenot, J.-F. (2021). Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review. https://doi.org/10.1007/s00228-021-03090-4/Published

Kuitunen, I., & Renko, M. (2023). Honey for acute cough in children — a systematic review. European Journal of Pediatrics, 182, 3949–3956. https://doi.org/10.1007/s00431-023-05066-1

Matthys, H., Köhler, S., & Kamin, W. (2013). Safety and Tolerability of EPs 7630 in Clinical Trials. Advances in Pharmacoepidemiology & Drug Safety, 02(05). https://doi.org/10.4172/2167-1052.1000143

European Medicines Agency. (2024). European Union herbal monograph on Pelargonium sidoides DC; Pelargonium reniforme Curt., radix Final - Revision 2. https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-pelargonium-sidoides-dc-pelargonium-reniforme-curt-radix-revision-2_en.pdf

Baraniak, J., & Kania-Dobrowolska, M. (2020). Pelargonium root (Pelargonium sidoides DC) extract in paediatric patients - food supplement or medicine? In Herba Polonica (Vol. 66, Issue 2, pp. 28–33). Sciendo. https://doi.org/10.2478/hepo-2020-0009

Malesker, M. A., Callahan-Lyon, P., Ireland, B., & Irwin, R. S. (2017). Pharmacologic and Nonpharmacologic Treatment for Acute Cough Associated With the Common Cold CHEST Expert Panel Report. CHEST, 152, 1021–1037. https://doi.org/10.1016/j.chest.2017.08.009

Winck, L. M., Boechat, M. M., Alves, B. M. C. S., Barros, D. S. L., Lima, R. F., Reis, T. M. dos, & Santana, R. (2025). Management of acute cough. Revista Brasileira de Medicina de Família e Comunidade, 20(47), 3991. https://doi.org/10.5712/rbmfc20(47)3991

Best Practice Advocacy Centre New Zealand. (2023). Cough medicines: do they make a difference? https://bpac.org.nz/2023/cough-medicines.aspx

Views:

54

Downloads:

14

Published
2025-12-30
Citations
How to Cite
Aleksandra Grygorowicz, Klaudia Baran, Michał Ględa, Michał Szyszka, Weronika Radecka, Weronika Kozak, Agnieszka Szreiber, Karol Grela, Karolina Nowacka, Kamil Jabłoński, & Anna Woźniak. (2025). ANTITUSSIVE PHARMACOTHERAPY IN ACUTE COUGH: EFFICACY, SAFETY, AND CURRENT CLINICAL EVIDENCE. International Journal of Innovative Technologies in Social Science, 2(4(48). https://doi.org/10.31435/ijitss.4(48).2025.4642

Most read articles by the same author(s)

<< < 1 2